How to achieve international action on falsified and substandard medicines
- 13 November 2012
- Vol. 345 (nov13 22) , e7381
- https://doi.org/10.1136/bmj.e7381
Abstract
Substandard and falsified medicines kill patients, yet progress on the twin challenges of safeguarding the quality of genuine medicine and criminalising falsified ones has been held back by controversy over intellectual property rights and confusion over terms. Amir Attaran and colleagues propose a global treaty to overcome the problemsKeywords
This publication has 16 references indexed in Scilit:
- Why and How to Make an International Crime of Medicine CounterfeitingJournal of International Criminal Justice, 2011
- Analysis and characterization of heparin impuritiesAnalytical and Bioanalytical Chemistry, 2010
- New Enforcement Mechanisms Challenge the Legality of Generics in the Name of Public Health: The Emergence of Anti-Counterfeiting Legislation in East AfricaAfrican Journal of International and Comparative Law, 2010
- Follow the money: How the billions of dollars that flow from smokers in poor nations to companies in rich nations greatly exceed funding for global tobacco control and what might be done about itTobacco Control, 2010
- Multinational Medicines — Ensuring Drug Quality in an Era of Global ManufacturingNew England Journal of Medicine, 2009
- Diethylene glycol poisoningClinical Toxicology, 2009
- Antimalarial Drug Quality in the Most Severely Malarious Parts of Africa – A Six Country StudyPLOS ONE, 2008
- Manslaughter by Fake Artesunate in Asia—Will Africa Be Next?PLoS Medicine, 2006
- Murder by fake drugsBMJ, 2002
- Convention for the Suppression of Counterfeiting CurrencyAmerican Journal of International Law, 1932